Neumora Therapeutics Faces Securities Fraud Investigation Over Disclosure Violations
The Schall Law Firm investigates Neumora Therapeutics ($NMRA) for potential securities fraud involving false statements or material information omissions.
NMRAclass action lawsuitshareholder rights
